⌘K
Loading ticker…
As of 2026-08-24, Neuropace, Inc. Common Stock (NPCE) has a 3-month relative strength percentile of 22 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.7%, relative volume 0.52×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
NPCE is in a stage 3 topping pattern, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -8.5% / -9.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
NPCE is held by 11 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $3M.
Held by 20 ETFs · $29M across latest filings · largest weight 0.46% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.01% |
| $20K |
| — |
| URTY | 0.00% | $16K | — |
| UWM | 0.01% | $15K | — |
| MSSM | 0.00% | $12K | — |
| HDG | 0.00% | $397 | — |
Showing 10 of 11 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NPCE Jan avg: 69.21% median: 32.39% win: 75% σ: 98.24% n: 4 2022-04-12 → 2026-07-31 | NPCE Feb avg: 2.67% median: 2.99% win: 50% σ: 8.64% n: 4 2022-04-12 → 2026-07-31 | NPCE Mar avg: -10.71% median: -9.68% win: 0% σ: 5.55% n: 4 2022-04-12 → 2026-07-31 | NPCE Apr avg: 6.28% median: 1.90% win: 60% σ: 13.12% n: 5 2022-04-12 → 2026-07-31 | NPCE May avg: -13.83% median: -11.00% win: 20% σ: 22.57% n: 5 2022-04-12 → 2026-07-31 | NPCE Jun avg: -5.98% median: -3.93% win: 40% σ: 12.20% n: 5 2022-04-12 → 2026-07-31 | NPCE Jul avg: -5.89% median: -7.57% win: 40% σ: 16.89% n: 5 2022-04-12 → 2026-07-31 | NPCE Aug avg: 27.19% median: 4.99% win: 75% σ: 67.83% n: 4 2022-04-12 → 2026-07-31 (current) | NPCE Sep avg: -1.86% median: -4.07% win: 50% σ: 12.14% n: 4 2022-04-12 → 2026-07-31 | NPCE Oct avg: -15.42% median: -13.73% win: 0% σ: 12.32% n: 4 2022-04-12 → 2026-07-31 | NPCE Nov avg: 28.95% median: 48.76% win: 75% σ: 52.31% n: 4 2022-04-12 → 2026-07-31 | NPCE Dec avg: 1.79% median: -0.03% win: 50% σ: 10.34% n: 4 2022-04-12 → 2026-07-31 |